Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Century Therapeutics Q1 EPS $0.89 Beats $0.16 Estimate, Sales $109.16M Beat $49.55M Estimate

Author: Benzinga Newsdesk | May 15, 2025 03:16pm
Century Therapeutics (NASDAQ:IPSC) reported quarterly earnings of $0.89 per share which beat the analyst consensus estimate of $0.16 by 456.25 percent. This is a 297.78 percent increase over losses of $(0.45) per share from the same period last year. The company reported quarterly sales of $109.16 million which beat the analyst consensus estimate of $49.55 million by 120.31 percent. This is a 12.67K percent increase over sales of $855.00 thousand the same period last year.

Posted In: IPSC


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist